Could We Reduce the Prevalence of Inflammation among Patients with Chronic Kidney Disease?

Publisher： Karger

E-ISSN： 1660-2110|101|4|c198-c199

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.101, Iss.4, 2005-08, pp. : c198-c199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The prevalence of anemia in patients with chronic kidney disease

By McClellan William   Aronoff Stephen L.   Bolton W. Kline   Hood Sally   Lorber Daniel L.   Tang K. Linda   Tse Thomas F.   Wasserman Brian   Leiserowitz Marc  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1501-1510

Informa Healthcare

Access to resources Recommend Favorite

Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease

By Bao Yu-Shi   Na Shi-Ping   Jia Xi-Bei   Liu Rui-Chan   Wang Ming-Ao   Yu Cheng-Yuan   Mu Su-Hong   Xie Ru-Juan  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 379-384

Informa Healthcare

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite

Inhaled Corticosteroids May Reduce Neutrophilic Inflammation in Patients with Stable Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 71-76

Karger

Access to resources Recommend Favorite

Prevalence, awareness and treatment of chronic kidney disease among middle‐aged and elderly: The China Health and Retirement Longitudinal Study

By  

NEPHROLOGY, Vol. 20, Iss. 7, 2015-07 ,pp. : 474-484

John Wiley & Sons Inc

Access to resources Recommend Favorite